8-K/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________

FORM 8-K/A

______________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 10, 2022

______________________________

LIFEVANTAGE CORPORATION

(Exact name of registrant as specified in its charter)

______________________________

Delaware	001-35647	90-0224471
(State or other jurisdiction of<br>incorporation or organization)	(Commission File Number)	(IRS Employer<br>Identification No.)

3300 Triumph Blvd., Suite 700

Lehi, Utah 84043

(Address of principal executive offices, including zip code)

(801) 432-9000

(Registrant's telephone number)

_____________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Common Stock, par value $0.0001	LFVN	The Nasdaq Stock Market LLC
Title of each class	Trading Symbol(s)	Name of each exchange on which registered

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Explanatory Note

This amendment to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 17, 2022, is being filed solely to correct the number of members of the board of directors of the Company seeking election and the fiscal year of their term, and the fiscal year for the ratification of selection of the independent registered public accounting firm. No other content of the original report has been changed.

Item 5.07	Submission of Matters to a Vote of Security Holders.

LifeVantage Corporation (the “Company”) held its fiscal 2023 annual meeting of stockholders on November 10, 2022 (the “Annual Meeting”). Of the 12,560,035 shares of the Company’s common stock outstanding as of the record date, 8,369,050 shares, or 66.63% were represented at the Annual Meeting either in person or by proxy. The following proposals were submitted to a vote of the Company’s stockholders at the Annual Meeting:

1.    To elect the following seven director nominees to the Company’s board of directors to hold office until the Company’s fiscal 2024 annual meeting of stockholders or until their respective successors are elected and qualified:

Mr. Michael A. Beindorff	Mr. Raymond B. Greer
Ms. Erin Brockovich	Mr. Darwin K. Lewis
Mr. Steven R. Fife	Mr. Garry Mauro
Ms. Cynthia Latham

2.    To approve, on an advisory basis, a resolution approving the compensation of the Company’s named executive officers;

3. To ratify the selection of WSRP, LLC as the Company’s independent registered public accounting firm for the Company’s fiscal year ending June 30, 2023; and

4. To approve an amendment to the 2017 Long-Term Incentive Plan.

The proposals submitted to a vote of the Company’s stockholders at the Annual Meeting are more fully described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on September 30, 2022.

The final voting results of each proposal were as follows:

Proposal 1 – Election of Directors: The Company’s stockholders elected each of the seven director nominees listed above to the Company’s board of directors to serve until the Company’s fiscal 2024 annual meeting of stockholders or until their respective successors are elected and qualified. Votes cast were as follows:

	For	Against	Abstain	Broker Non-Votes
Mr. Michael A. Beindorff	3,663,777	390,841	12,961	4,301,471
Ms. Erin Brockovich	3,467,258	583,089	17,232	4,301,471
Mr. Steven R. Fife	3,666,300	392,432	8,847	4,301,471
Mr. Raymond B. Greer	3,569,953	479,076	18,550	4,301,471
Ms. Cynthia Latham	3,727,975	327,370	12,234	4,301,471
Mr. Darwin K. Lewis	3,796,342	246,155	25,082	4,301,471
Mr. Garry Mauro	3,476,604	582,198	8,777	4,301,471

Proposal 2 – Approval of Compensation of the Company’s Named Executive Officers. The Company’s stockholders approved, on an advisory and non-binding basis, the compensation of the Company’s named executive officers. Votes cast were as follows:

For	Against	Abstain	Broker Non-Votes
3,388,050	659,309	20,220	4,301,471

Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm: The Company’s stockholders ratified the selection of WSRP, LLC as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2023. Votes cast were as follows:

For	Against	Abstain
7,940,835	103,034	325,181

Proposal 4 – Approval of an Amendment to the 2017 Long Term Incentive Plan:: The Company’s stockholders approved the amendment to the 2017 Long-Term Incentive Plan. Votes cast were as follows:

For	Against	Abstain	Broker Non Votes
3,471,779	575,564	20,236	4,301,471

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 18, 2022	LIFEVANTAGE CORPORATION<br><br><br><br>By: /s/ Steven R. Fife<br><br>Name: Steven R. Fife<br><br>Title: President and Chief Executive Officer